Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants
ClinicalTrials.gov study NCT06727396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal
ClinicalTrials.gov study NCT06177041. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
ClinicalTrials.gov study NCT05222932. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
ClinicalTrials.gov study NCT05945823. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects
ClinicalTrials.gov study NCT06350279. IPD Sharing: NO. Countries: 1. Publications: 0.
PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
ClinicalTrials.gov study NCT00281619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL
ClinicalTrials.gov study NCT04624984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
ClinicalTrials.gov study NCT04164238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Inhibitor Plus G-CSF in Recurrent/Metastatic NPC With First-line Treatment Failure
ClinicalTrials.gov study NCT05222035. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00457782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intrapatient Comparison of STN and GPi tTIS in PD
ClinicalTrials.gov study NCT07018388. IPD Sharing: NO. Countries: 1. Publications: 0.
CAN1012 Combined With PD-1 in Patients With Solid Tumors
ClinicalTrials.gov study NCT06410703. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT05201729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnosis of PD and PD Progression Using DWI
ClinicalTrials.gov study NCT02837172. IPD Sharing: YES. Countries: 1. Publications: 0.
Is Long-term Use of Amantadine Effective in PD?
ClinicalTrials.gov study NCT04260581. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults
ClinicalTrials.gov study NCT04479865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects
ClinicalTrials.gov study NCT06019065. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
ClinicalTrials.gov study NCT00941616. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT03913949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Propor
ClinicalTrials.gov study NCT06170788. IPD Sharing: YES. Countries: 26. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.